Applied DNA Valuation
| APDN Stock | USD 0.18 0.00 0.000006% |
Applied DNA seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Applied DNA Sciences from analyzing the firm fundamentals such as Profit Margin of (2.14) %, return on equity of -0.76, and Current Valuation of 3.78 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Applied DNA's valuation include:
Price Book 1.0358 | Enterprise Value | Enterprise Value Ebitda (0.34) | Price Sales 2.8909 | Enterprise Value Revenue 1.1011 |
Undervalued
Today
Please note that Applied DNA's price fluctuation is out of control at this time. Calculation of the real value of Applied DNA Sciences is based on 3 months time horizon. Increasing Applied DNA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Applied DNA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Applied Stock. However, Applied DNA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.18 | Real 0.5 | Target 1.5 | Hype 0.19 | Naive 0.18 |
The intrinsic value of Applied DNA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Applied DNA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Applied DNA Sciences helps investors to forecast how Applied stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Applied DNA more accurately as focusing exclusively on Applied DNA's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Applied DNA's intrinsic value based on its ongoing forecasts of Applied DNA's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Applied DNA's closest peers.
Applied DNA Cash |
|
Applied Valuation Trend
Knowing Applied DNA's actual value is paramount for traders when making sound investment determinations. Using both Applied DNA's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Applied DNA Total Value Analysis
Applied DNA Sciences is presently forecasted to have valuation of 3.78 M with market capitalization of 9.82 M, debt of 739.16 K, and cash on hands of 4.68 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Applied DNA fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.78 M | 9.82 M | 739.16 K | 4.68 M |
Applied DNA Investor Information
About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied DNA Sciences recorded a loss per share of 1.82. The entity last dividend was issued on the 1st of November 2019. The firm had 1:20 split on the 25th of April 2024. Based on the key measurements obtained from Applied DNA's financial statements, Applied DNA Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Applied DNA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Applied DNA has an asset utilization ratio of 26.83 percent. This suggests that the Company is making $0.27 for each dollar of assets. An increasing asset utilization means that Applied DNA Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Applied DNA Ownership Allocation
Applied DNA holds a total of 55.19 Million outstanding shares. Applied DNA Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Applied DNA Profitability Analysis
The company reported the previous year's revenue of 3.43 M. Net Loss for the year was (7.09 M) with profit before overhead, payroll, taxes, and interest of 850.98 K.About Applied DNA Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Applied DNA Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Applied DNA Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Applied DNA's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Applied DNA's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Applied DNA. We calculate exposure to Applied DNA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Applied DNA's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.2 M | 1.1 M | |
| Pretax Profit Margin | (1.86) | (1.95) | |
| Operating Profit Margin | (3.68) | (3.86) | |
| Net Loss | (1.83) | (1.93) | |
| Gross Profit Margin | 0.34 | 0.32 |
Applied DNA Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 4 M |
Applied DNA Current Valuation Indicators
Applied DNA's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Applied DNA's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Applied DNA, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Applied DNA's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Applied DNA's worth.When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share | Quarterly Revenue Growth (0.73) | Return On Assets | Return On Equity |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.